Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of HB0056 in Moderate to Severe Asthma
NCT07899996Phase 2Recruiting
- Sponsor
- Shanghai Huaota Biopharmaceutical Co., Ltd.
- Start
- Aug 2025
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
A Phase 2 trial of HB0056 in asthma, sponsored by Shanghai Huaota Biopharmaceutical Co., Ltd.. Started Aug 2025; status: recruiting.
02
Drugs
HB0056
03
Conditions
asthma
Beyond the preview
Go deeper on NCT07899996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07899996.